Favorite this paper

INTRODUCTION AND OBJECTIVES: Cervical cancer normally goes slowly and presents one of the highest potential for prevention and cure in the routine of primary attention to women health. The oncotic cytology is the main method of cervical cancer tracking, although its false-negative test rate can exceed 50%. The following proposed by the Brazilian Policy for Cervical Cancer Tracking considers only the result of cytology to doctor’s conduct in health system. Thus many women with alterations that can worsen can go unnoticed by the health system, making the professionals of the field to request complementary exams and tests with no justificatory supported by the Policy. To identify the justificatory for those during 2014 in an institution on cancer prevention. METODOLOGY: The request for histopathological test in the Cervical Cancer Information System (SISCOLO) forecasts an altered cytology and, in cases with normal cytology, the field “others” is marked, generating reports with “other cancer”. We looked at the professional justificatory relating them with the Policy. RESULTS AND CONCLUSION: From the 341 analyzed medical records 283 (83%) presented normal cytology, and from those 283, 272 (96.5%) had colposcopy been made with no specific and/or evident justificatory. Only 11 (3.9%) presented justificatory, but those did not belong to the Policy.: It was observed many altered colposcopy in patients with normal cytology. The importance of deeper discussions about health professionals conduct before the normal oncotic cytology results has been ascertained as well as to consider adjustments in the Policy according to the national scenery.